相似文献
1
A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia.
Am J Trop Med Hyg. 2010 Mar;82(3):379-85. doi: 10.4269/ajtmh.2010.09-0573.
2
Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.
Am J Trop Med Hyg. 2009 Dec;81(6):1056-61. doi: 10.4269/ajtmh.2009.09-0356.
3
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Lancet. 1997 Jul 5;350(9070):18-22. doi: 10.1016/S0140-6736(96)11094-1.
4
Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
Ophthalmic Epidemiol. 2000 Mar;7(1):27-39.
5
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Trans R Soc Trop Med Hyg. 2007 Aug;101(8):777-85. doi: 10.1016/j.trstmh.2007.03.018. Epub 2007 May 24.
6
Human loiasis in a Cameroonian village: a double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen.
Am J Trop Med Hyg. 2004 Aug;71(2):211-5.
7
A novel antigen biomarker for detection of high-level of Loa loa microfilaremia.
PLoS Negl Trop Dis. 2024 Sep 3;18(9):e0012461. doi: 10.1371/journal.pntd.0012461. eCollection 2024 Sep.
8
Absence of Microfilaremia among Newly Arrived Congolese Refugees in Texas.
Am J Trop Med Hyg. 2017 Dec;97(6):1833-1835. doi: 10.4269/ajtmh.17-0337. Epub 2017 Aug 31.
9
Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections.
Parasit Vectors. 2018 Apr 4;11(1):223. doi: 10.1186/s13071-018-2799-3.
10
[Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Bull Soc Pathol Exot. 1995;88(3):105-12.
引用本文的文献
1
Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial.
Nat Commun. 2025 Jul 4;16(1):6191. doi: 10.1038/s41467-025-61479-6.
2
Advances in preclinical platforms of for filarial neglected tropical disease drug and diagnostics research.
Front Trop Dis. 2021 Nov 8;2. doi: 10.3389/fitd.2021.778724.
3
Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions.
Syst Rev. 2021 Nov 4;10(1):294. doi: 10.1186/s13643-021-01835-x.
4
Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial.
Clin Infect Dis. 2022 Aug 24;75(1):19-27. doi: 10.1093/cid/ciab906.
5
Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of Microfilariaemia with Prolonged Repeated Courses of Albendazole.
Am J Trop Med Hyg. 2018 Jul;99(1):112-115. doi: 10.4269/ajtmh.17-0664. Epub 2018 May 3.
6
Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa.
Parasit Vectors. 2018 May 2;11(1):275. doi: 10.1186/s13071-018-2852-2.
7
Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections.
Parasit Vectors. 2018 Apr 4;11(1):223. doi: 10.1186/s13071-018-2799-3.
8
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Int Health. 2018 Mar 1;10(suppl_1):i49-i53. doi: 10.1093/inthealth/ihx051.
9
Repurposing drugs for the treatment and control of helminth infections.
Int J Parasitol Drugs Drug Resist. 2014 Jul 30;4(3):185-200. doi: 10.1016/j.ijpddr.2014.07.002. eCollection 2014 Dec.
本文引用的文献
1
Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.
Am J Trop Med Hyg. 2009 Dec;81(6):1056-61. doi: 10.4269/ajtmh.2009.09-0356.
2
Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols.
PLoS Negl Trop Dis. 2009 Jul 14;3(7):e477. doi: 10.1371/journal.pntd.0000477.
3
Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice.
Parasitol Res. 2009 Sep;105(3):853-61. doi: 10.1007/s00436-009-1471-4. Epub 2009 May 21.
4
Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine.
Parasitol Res. 2009 Jun;104(6):1407-16. doi: 10.1007/s00436-009-1341-0. Epub 2009 Feb 17.
5
Mefloquine--an aminoalcohol with promising antischistosomal properties in mice.
PLoS Negl Trop Dis. 2009;3(1):e350. doi: 10.1371/journal.pntd.0000350. Epub 2009 Jan 6.
6
Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.
Antimicrob Agents Chemother. 2008 May;52(5):1840-2. doi: 10.1128/AAC.01478-07. Epub 2008 Mar 3.
7
Artemisinins and synthetic trioxolanes in the treatment of helminth infections.
Curr Opin Infect Dis. 2007 Dec;20(6):605-12. doi: 10.1097/QCO.0b013e3282f19ec4.
8
Pumping iron: a potential target for novel therapeutics against schistosomes.
Trends Parasitol. 2007 Dec;23(12):583-8. doi: 10.1016/j.pt.2007.08.018. Epub 2007 Oct 24.
9
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Trans R Soc Trop Med Hyg. 2007 Aug;101(8):777-85. doi: 10.1016/j.trstmh.2007.03.018. Epub 2007 May 24.
10
What are the mechanisms associated with post-ivermectin serious adverse events?
Trends Parasitol. 2006 Jun;22(6):244-6. doi: 10.1016/j.pt.2006.04.006. Epub 2006 Apr 24.
Zotero 插件